Funded startups/Terrestrial Bio, Inc.
TB

Terrestrial Bio, Inc.

SEC filing
Biotechnology · Woburn, MA
Form D on EDGAR
Amount raised$57.3Msold at filing
Total offering$83.5M$26.2M still open
Investors in the raise16count reported to the SEC
FiledMar 19, 2026first sale Mar 4, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Linda TusseyExecutive Officer
Kathryn KousdaExecutive Officer, Director
Livio ValentiExecutive Officer
Ann DeWittDirector
Fenel EloiDirector
Peter KolchinskyDirector
Rachel ShaExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
DMar 19, 2026$57.3M$83.5MEDGAR
DSep 10, 2025$7.9M$10MEDGAR
DFeb 26, 2025$8.4M$10MEDGAR